Lacticin Q (LnqQ) produced by Lactococcus lactis QU 5 is an unmodified linear bacteriocin, which is synthesized without an N-terminal leader peptide. In vitro synthesis and in vivo expression of LnqQ have revealed the intracellular toxicity of this leaderless peptide, as well as the necessity of a dedicated secretion and self-immunity system of producer cells. Further DNA sequencing and analysis have discovered 11 putative orf genes at the LnqQ locus. None of the orf genes showed similarities to any of the bacteriocin biosynthetic genes characterized to date; however, six orf genes (orf2q-7q), not including the structural gene (lnqQ), were highly conserved at the lacticin Z locus (orf2z-7z), which is a LnqQ homologue produced by L. lactis QU 14. ORF2q (ORF2z), the gene of which is located upstream of the structural gene, is a putative transcriptional regulator, whereas ORF6q and ORF7q (ORF6z and ORF7z) form a putative ATPbinding cassette transporter. The ORF3q-5q (ORF3z-5z) are all predicted to be membrane proteins with no clear functions. Co-expression of LnqQ and ORF3q-7q in a heterologous host allowed the extracellular production of LnqQ; additionally, the expression of ORF3q-7q rendered the host cells immune to LnqQ. This self-immunity was facilitated possibly by two means; firstly, by secreting the active LnqQ peptides, thus reducing the intracellular toxicity, and secondly, by protecting the host cells from extracellularly released LnqQ. This is the first report, to our knowledge, that describes intracellular toxicity of a leaderless bacteriocin and provides a rare example of biosynthetic genes that are required for bacteriocin secretion and immunity.
INTRODUCTION
Bacteriocins are ribosomally synthesized, extracellularly released antimicrobial peptides or proteins produced by a wide variety of bacteria (Klaenhammer, 1993) . Small peptide bacteriocins of Gram-positive bacteria are classified mainly into two groups: the class I lantibiotics that contain posttranslationally formed lanthionine or methyllanthionine bridges, and the non-lanthionine-containing class II bacteriocins (Cotter et al., 2005) . Class II bacteriocins are generally small (,10 kDa), heat-stable peptides and are subdivided into several subclasses, including pediocin-like bacteriocins (class IIa), two-peptide bacteriocins (class IIb), cyclic bacteriocins (class IIc) and non-pediocin-like, one-peptide bacteriocins (class IId) (Cotter et al., 2005) .
Bacteriocin biosynthesis is carried out by several biosynthetic proteins that are encoded near the bacteriocin structural gene and which are usually organized in an operon (Nes et al., 1996) . General functions of these proteins are (i) to mediate the maturation the bacteriocin peptide, (ii) to transport the bacteriocin outside the producer cells (secretion) and (iii) to protect the producer cells from their own bacteriocins (self-immunity). The majority of bacteriocins are synthesized as prepeptides that consist of an Nterminal leader sequence and a C-terminal propeptide, the latter of which undergoes post-translational modification events to become active. An N-terminal leader sequence plays key roles during this process, to prevent the prepeptide from being active inside the producer cell before secretion and to act as a recognition site for the post-translational modification and/or the dedicated transporter system (Chatterjee et al., 2005; Nes et al., 1996) . Moreover, some typical sequences have been recognized in N-terminal leaders, so it is predictable which types of proteins are involved in bacteriocin biosynthesis. There are, however, some class IId bacteriocins that are synthesized without an N-terminal leader sequence and are thus called leaderless bacteriocins. Enterocin L50, produced by Enterococcus faecium L50, is an early identified two-peptide (EntL50A and EntL50B), leaderless bacteriocin (Cintas et al., 1998) , and some identical or homologous bacteriocins have been found in other enterococcal species (Floriano et al., 1998; Martín-Platero et al., 2006; Sánchez-Hidalgo et al., 2003; Yamamoto et al., 2003) . Enterocin L50 was successfully expressed and secreted by two yeast hosts through their general secretory pathways (Basanta et al., 2009 (Basanta et al., , 2010 ; however, the genes required for its secretion and immunity have not yet been determined.
We have identified two homologous leaderless bacteriocins, lacticin Q (LnqQ) and lacticin Z (LnqZ), produced by Lactococcus lactis QU 5 and L. lactis QU 14, respectively (Fujita et al., 2007; Iwatani et al., 2007) . LnqQ/Z have no significant similarity to any members of the enterocin L50 family; in contrast, they share some similarities (46~48 %) to other leaderless bacteriocins, such as BHT-B from Streptococcus rattus strain BHT (Hyink et al., 2005) , aureocin A53 from Staphylococcus aureus strain A53 (Netz et al., 2002) and epidermicin NI01 from Staphylococcus epidermidis strain 224 (Sandiford & Upton, 2012) . Aureocin A53 and epidermicin NI01 are both plasmid encoded and share similar genetic organizations of their gene loci, suggesting the involvement of those genes (seven genes, not including the structural gene) in the secretion and/or the immunity of these two bacteriocins (Nascimento et al., 2012; Sandiford & Upton, 2012) . On the other hand, the gene locus of BHT-B shows a different organization from the two bacteriocin loci mentioned above, thus indicating a variation of this type of bacteriocin gene locus.
In this study, we firstly sequenced the flanking regions of LnqQ/LnqZ structural genes (lnqQ/lnqZ); in addition, a variety of heterologous expression of the gene(s) of interest was performed to identify the genetic requirement for the secretion and self-immunity of LnqQ/Z. We also focused on the intracellular toxicity of this leaderless bacteriocin, which is sometimes overlooked but is important for the study of leaderless bacteriocin biosynthesis.
METHODS
Bacterial strains and culture conditions. Bacterial strains and plasmids used in this study are listed in Table 1 . Lactococcus strains were grown in M17 broth (Merck) containing 0.5 % (w/v) glucose (GM17) at 30 uC. Bacillus coagulans JCM 2257
T was grown in tryptic soy broth (Difco Laboratories) supplemented with 0.6 % (w/v) yeast extract (Nacalai Tesque) at 37 uC with shaking. Escherichia coli DH5a was grown in Luria-Bertani broth (Difco) at 37 uC with shaking. The agar media were prepared by the addition of 1.5 % (w/v) agar (Nacalai Tesque) to the broth media, and overlay agars were prepared by the addition of 1.0 % (w/v) agar to the broth media. As necessary, culture media were supplemented with 10 mg chloramphenicol ml 21 for L. lactis and 34 mg chloramphenicol ml 21 and 100 mg ampicillin ml 21 for E. coli. Nisin induction was conducted by the addition of 
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10 ng nisin ml 21 (Sigma-Aldrich) to the bacterial culture when OD 660 reached~0.5. The bacterial growth (OD 660 ) was monitored by using a biophotorecorder (TVS062CA; Advantec) and the data were represented as the mean values±SD of three independent experiments. DNA manipulations and transformation. DNA manipulation and other molecular cloning techniques were performed basically as described by Sambrook & Russell (2001) . KOD Plus DNA polymerase (Toyobo), Ex Taq polymerase (Takara Bio), Ligation-High (Toyobo) and restriction enzymes (Roche Applied Science) were used according to the suppliers' instructions. QIAquick PCR Purification kit (Qiagen) was used to purify PCR products as well as the DNA fragments derived from other modification reactions. Synthetic oligonucleotides were obtained from Hokkaido System Science and DNA-sequencing reactions were conducted by FASMAC. All the transformations were carried out by electroporation using MicroPulser (Bio-Rad Laboratories) by following the procedures described by Holo & Nes (1995) .
DNA amplification, sequencing and analysis. An inverse-PCR technique (Ochman et al., 1988) was applied to amplify the flanking regions of lnqQ and lnqZ. The total DNA fragments of L. lactis QU 5 and L. lactis QU 14 were isolated using the MagExtractor-Genomekit (Toyobo). Isolated DNA fragments were digested with BamHI, EcoRI, HindIII, SacI, SpeI or XbaI, and appropriate restriction enzymes were selected by Southern blotting and hybridization procedures (Sambrook & Russell, 2001) , using the structural genes as probes. DNA fragments digested with the selected enzymes were then self-ligated and used as templates for inverse-PCR techniques. The amplified fragments were sequenced either directly or after cloning into pGEM-T vector (Promega). Based on the sequence information obtained, new sequence-specific primers were designed for further inverse-PCR and subsequent DNA sequencing. Computer analyses of DNA and protein sequences were performed by GENETYX-WIN ver.8.0 and ATGC ver.5.0 (Software Development). ORF prediction was performed using ORF Finder (http://www.ncbi.nlm.nih.gov/projects/gorf/) and the BLAST program (http://blast.ncbi.nlm.nih.gov/Blast.cgi) of the National Center for Biotechnology Information. SOSUI (http://bp.nuap.nagoyau.ac.jp/sosui/) and TMHMM (http://www.cbs.dtu.dk/services/TMHMM/) programs were used for further characterization of individual ORFs.
In vitro synthesis of LnqQ. The structural gene of LnqQ (lnqQ) was amplified by PCR with the primers lnqQ-F (59-ATGGCAGGGTTTT-TAAAAGTAGT-39) and lnqQ-XbaI-R (59-CCTTATATAAGATTAAC-TCTAGATGATC-39) to add an XbaI site at the 39 end. The amplified fragments were then digested with XbaI and ligated to the pTD1 (Shimadzu), which was preliminarily digested with EcoRV and XbaI. The ligated product, pTDlnqQ, was introduced into E. coli DH5a for plasmid replication and DNA sequencing. A part of pTDlnqQ encompassing a T7 promoter, lnqQ, and a terminator region was amplified by PCR and was purified through the QIAquick PCR Purification kit. The purified DNA fragments were quantified by NanoDrop ND-1000 (Nano-Drop Technologies), 100 ng of which was used as the template DNA for in vitro RNA transcription by Thermo T7 RNA polymerase (Toyobo). In vitro translation of the reaction mixture was performed by Transdirect insect cell (Shimadzu), according to the supplier's instructions, with a supplementary addition of 0.1 % (v/v, final concentration) Triton X-100 (Sigma-Aldrich) in the mixture. An in vitro transcription/translation using pTD1 as the DNA template was also carried out as a control reaction.
Heterologous expression of lnqQ genes. For the construction of pNZlnqQ, lnqQ was amplified with designed primers, PstI-lnqQ-F (59-TATAATGATTGCTGCAGAGAGAAAG-39) and lnqQ-XbaI-R (sequence given previously), to add PstI and XbaI sites at the 59 and 39 ends of the fragment, respectively. The amplified fragments were digested and ligated to the corresponding site of pNZ8048. The resulting plasmid, termed pNZlnqQ, was then introduced into L. lactis subsp. cremoris NZ9000 (L. lactis NZ9000), which was used as an expression host for nisin-controlled gene expression system (de Ruyter et al., 1996) . Another recombinant plasmid pNZA, supplied from our laboratory collection, was also introduced into L. lactis NZ9000. This pNZ8048-based recombinant plasmid encodes a 57 aa prepeptide (NukA) of a type AII lantibiotic nukacin ISK-1, produced by Staphylococcus warneri ISK-1 (Aso et al., 2004) . Because nukacin ISK-1 requires a modification enzyme (NukM) for its maturation (Nagao et al., 2005; Shioya et al., 2010) , heterologously expressed NukA is solely inactive and thus, pNZA was used as a control plasmid for pNZlnqQ in this study.
For pMG36c-based plasmid construction, lnqQ was amplified with designed primers, SacI-lnqQ-F (59-TGAGCTCTGCAAAGAGAAA-GCGTG-39) and lnqQ-XbaI-R (sequence given previously), and then cloned into the corresponding site of pMG36c to generate a recombinant plasmid pMGlnqQ, which places lnqQ under the control of the lactococcal constitutive promoter P 32 (van de Guchte et al., 1989) . The region orf3q-7q was amplified with designed primers, XbaI-orf3-F (59-CTTATATAAGGTTAATTCTAGATGATTTTG-39) and orf7-SphI-R (59-ATCTCGCATGCCTTTATTAAACAAAACAC-39), to add XbaI and SphI sites at the 59 and 39 ends of the fragment, respectively. The amplified fragment was then digested and ligated to the corresponding site of pMGlnqQ, resulting in a rearrangement of lnqQ and orf3q-7q under the control of P 32 on a newly constructed plasmid, pLNQ. The digested fragment encompassing orf3q-7q was also ligated to the corresponding site of pMG36c, to arrange these orf genes under the control of P 32 , but this fragment lacked lnqQ (pLNQDQ). All the pMG36c-based recombinant plasmids were also introduced into L. lactis NZ9000 to enable the constitutive expression of the gene(s) of interest.
Bacteriocin activity assay and LC/MS analysis. Purification of LnqQ from the culture supernatants of L. lactis QU 5 and L. lactis NZ9000 recombinants was performed as described previously (Fujita et al., 2007) . Culture supernatants were obtained by doublecentrifugations of overnight cultures at 13 000 g for 5 min at 4 uC. The harvested cells were resuspended in 50 % (v/v) acetonitrile, containing 0.1 % (v/v) trifluoroacetic acid, and were homogenized by using Multi-beads shocker (Yasui Kikai) with a triplicate round of 2700 r.p.m. for 30 s at 4 uC. Cell-free extracts were obtained after the centrifugation of the homogenized mixture at 12 000 g for 5 min at 4 uC. For the bacteriocin assay and LC/MS analysis, the acetonitrile present in the cell-free extracts was removed by SpeedVac (Thermo Fisher Scientific K.K.) drying, and the precipitates were resuspended in adequate amounts of 50 mM sodium phosphate buffer (pH 6.0).
The colony-overlay assay with B. coagulans JCM 2257
T as an indicator strain was simply performed to detect the extracellular antimicrobial activities of L. lactis NZ9000 recombinants. Bacteriocin activities of in vitro synthesis mixtures, culture supernatants or cell-free extracts were detected by the spot-on-lawn method, as described previously (Ennahar et al., 2001) . The self-immunity of L. lactis NZ9000 recombinants was also evaluated by the spot-on-lawn method. Molecular mass analyses of in vitro synthesized-or heterologously expressed-LnqQ were performed using the Agilent 1100 HPLC system (Agilent Technologues) equipped with JMS-T100LC ESI-TOF MS (JEOL), according to a previous report (Zendo et al., 2008) , but a higher gradient of 10 % (v/v) acetonitrile was applied.
RESULTS
DNA sequence analyses of lnqQ/lnqZ gene loci As a consequence of sequencing the PCR products, a 16.7 kb nucleotide sequence of the regions flanking lnqQ and an 8.4 kb nucleotide sequence of the regions flanking lnqZ were obtained. ORF analysis of the obtained sequences revealed 11 putative orf genes in the vicinity of lnqQ and nine putative orf genes in the vicinity of lnqZ that were temporarily named in number order from the 59 to the 39 end of the fragment (from orf1Q to orf11Q for the lnqQ locus, and from orf1Z to orf9Z for the lnqZ locus). A schematic overview of the two gene loci is illustrated in Fig. 1 and the annotated characteristics of deduced protein products are shown in Table 2 .
At the lnqQ locus, orf1q, located 2 kb upstream of lnqQ, encodes a collagen-binding protein that is found in the L. lactis IL1403 genome. The GC content of this region is similar to that of the L. lactis genome (mean 35 %), whereas the regions encompassing orf2q-7q and orf8q-11q show lower GC contents (means 26 and 31 %, respectively). The orf2q, divergently located upstream of lnqQ, encodes a putative transcriptional regulator, which shares some homology with TetR family proteins. The orf3q-7q, located downstream of lnqQ, are all oriented in the same direction, in which the orf3q-6q are tightly organized in overlapping clusters and the orf7q is located 66 bp downstream of orf6q. Deduced products of orf3q-5q are all predicted to be membrane proteins but with unknown functions, whereas ORF6q and ORF7q showed considerable similarities to ATPbinding cassette (ABC) transporter components. The orf8q encodes a putative transcriptional regulator with a DNAbinding motif, and the products of orf9q-11q are predicted to function in DNA replication and recombination.
The orf2q-7q cluster was highly conserved at the lnqZ locus (orf2z-7z), with a constant nucleotide identity (ca 75 %). This similarity is, however, disrupted right outside the region (upstream of orf2q/2z and downstream of orf7q/7z). Similar to the lnqQ locus, orf3z-6z are organized in overlapping clusters, whereas orf7z is located 83 bp downstream of orf6z. The homologies between the deduced products of orf2q-7q and orf2z-7z ranged from 60 to 80 % (Table 2) . ORF2q/2z, ORF3q/3z, ORF6q/6z and ORF7q/7z showed approximately 80 % homology to each other, while relatively low homologies were observed in ORF4q/4z (60 %) and ORF5q/5z (69 %). Transmembrane topology predictions by SOSUI and TMHMM programs indicated the presence of multiple transmembrane sequences in each of the ORF3q-6q and ORF3z-6z, which strongly supported the annotated characteristics of these ORFs functioning as membrane proteins. ORF7q/7z were both predicted to be ATP-binding proteins of an ABC transporter, which was confirmed by the presence of the two main motifs, Walker A and Walker B (Walker et al., 1982) , in their primary structures (data not shown).
It is also noteworthy that some consensus sequences were recognized in the non-coding regions of lnqQ/Z loci. The 200 bp upstream region of lnqQ/Z is the most conserved region between the two loci (86 %), in which putative promoter sequences, 210 (TATAAT) and 235 (TAATAT), were found. This region also contains the consensus sequence of a 26 bp inverted repeat (59-GTAGTGCTAAA-ATGGTTTAGCACTAC-39) upstream of the 235 sequence. Another tight inverted repeat was recognized in the noncoding region between lnqQ/Z and orf3q/3z, which is, in contrast, considered as typical of a rho-independent transcription terminator because of the T-stretch following the stem-loop structure (data not shown).
As compared with other bacteriocin loci, there was no similarity observed between lnqQ/Z loci and aureocin A53 or epidermicin NI01 loci, whereas ORF6q/6z and ORF7q/ 7z share some homology to ORF3 and Abc2 at the bht-b locus of Streptococcus rattus BHT (Hyink et al., 2005) . The organization of the bht-b locus is similar to those of the lnqQ/Z loci, in that three more genes (abc1, orf1 and orf2) are wedged between the structural gene (bht-b) and ABC transporter genes (orf3 and abc2) in the same orientation. However, no significant similarity was found between the three protein products (Abc1, ORF1 and ORF2) and ORF3q-5q or ORF3z-5z.
Antimicrobial activity of in vitro synthesized LnqQ (sLnqQ)
To demonstrate the post-translational antimicrobial activity of in vitro sLnqQ, the structural gene lnqQ was solely cloned and applied to an in vitro transcription/translation reaction. The reaction mixture containing sLnqQ was spotted onto an indicator lawn of B. coagulans JCM 2257 T . As a result, a clear inhibition zone of growth was observed in a spot of sLnqQ, which was, in contrast, not observed in a spot of the control Fig. 1 . Schematic overview of the lnqQ/lnqZ gene loci. The arrow indicates the appropriate size, location and direction of each ORF at the lnqQ locus (a) and the lnqZ locus (b). The orf genes sharing some homology are filled in the same manner. Names in parentheses are genes that are potentially involved in LnqQ/Z biosynthesis, as described in the discussion section.
reaction mixture (Fig. 2) . Since sLnqQ was synthesized within insect cell extracts, the initial methionine of sLnqQ was not theoretically formylated; however, possibly due to the complexity or the small amount of the reaction mixture, the theoretical mass of sLnqQ (5898 Da) could not be detected by LC/MS analysis.
Intracellular toxicity of heterologously expressed LnqQ
Induced expression of lnqQ alone in L. lactis NZ9000 (pNZlnqQ) resulted in growth suppression of the host cells (Fig. 3a) . Within 2 h after nisin induction, L. lactis NZ9000 (pNZlnqQ) drastically stopped growing and the optical density remained around 0.90 (mean), whereas the control strain harbouring pNZ8048 kept growing, to final OD 1.66 (mean). In addition, L. lactis NZ9000 (pNZA) expressing nukacin ISK-1 prepeptide (NukA) also kept growing without any considerable suppression.
Antimicrobial activity or the molecular mass of LnqQ was not detected in the 12 h cultured supernatant of L. lactis NZ9000 (pNZlnqQ); in contrast, a clear antimicrobial Fig. 2 . Antimicrobial activity of in vitro sLnqQ. The growth inhibition zone of B. coagulans JCM 2257 T was caused by a spot of the reaction mixture containing sLnqQ (right), whereas no inhibition zone was observed in the control reaction mixture (left).
Lacticin Q biosynthetic genes activity against B. coagulans JCM 2257
T was detected in the cell-free extract of nisin-induced L. lactis NZ9000 (pNZlnqQ) (Fig. 3b) . LC/MS analysis also revealed the molecular mass of intact LnqQ in the cell-free extract (Fig.  3c) , indicating that LnqQ was expressed, but was trapped intracellularly in the absence of a transporter that is dedicated to secret it outside the cell.
LnqQ production by a heterologous host
Considering the potential transcriptional terminator sequence between lnqQ and orf3q, the gene fragment encompassing orf3q-7q was cloned into pMGlnqQ, resulting in the rearrangement of lnqQ and orf3q-7q, lacking the putative terminator sequence, in the same orientation under the control of P 32 (pLNQ). In a colony-overlay assay, a clear inhibition zone was observed on the periphery of the colony of L. lactis NZ9000 (pLNQ), as well as for L. lactis QU 5 (LnqQ producer), which was not observed around the negative controls such as L. lactis NZ9000 (pMG36c), L. lactis NZ9000 (pMGlnqQ) or L. lactis NZ9000 (pLNQDQ) (Fig. 4a) . Thus, the heterologous production of LnqQ was only achieved by the co-expression of lnqQ and orf3q-7q (pLNQ). The 12 h cultured supernatants or cell-free extracts of tested strains were also spotted onto the indicator lawn of B. coagulans JCM 2257
T to confirm the expression and secretion of LnqQ. (Fig. 4b) . Results showed that LnqQ activity in the culture supernatant was detected only from L. lactis NZ9000 (pLNQ), whereas the activity was detected in the cell-free extract of L. lactis NZ9000 (pMGlnqQ), which confirmed the expression of LnqQ in this strain. LC/MS analysis revealed the molecular mass of intact LnqQ (5928 Da) in the culture supernatant of L. lactis NZ9000 (pLNQ) (data not shown). 
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Host cell immunity against exogenous and endogenous LnqQ
The spot-on-lawn method was applied to evaluate the host cell immunity against exogenous LnqQ. The purified LnqQ solution, adjusted at 10 mM concentration, was serially twofold diluted and spotted onto the indicator lawn of L. lactis recombinants. Results showed that serial inhibition zones, even at the lowest concentration of LnqQ, were observed on the lawn of L. lactis NZ9000 (pMG36c). In contrast, L. lactis NZ9000 (pLNQ) showed an improved immunity, which was confirmed by both the smaller number of and the smaller size of the inhibition zones. Moreover, the immunity level was further improved in L. lactis NZ9000 (pLNQDQ), which only expresses orf3q-7q (Fig. 5a ).
The growth of the recombinant strains in liquid culture was also monitored to evaluate the intracellular toxicity of LnqQ in the host cells. L. lactis NZ9000 (pMGlnqQ), constitutively expressing lnqQ alone, showed a prolonged lag phase compared with the control strain (pMG36c). This prolonged lag phase was, however, no longer observed in L. lactis NZ9000 (pLNQ), the growth of which was almost similar to that of the control strain (Fig. 5b) .
DISCUSSION
The biosynthesis of lactic acid bacteria bacteriocins is maintained by several biosynthetic proteins that are generally required for the post-translational modification (class I), processing and transport of bacteriocin, and self-immunity of the producer strain (Nes et al., 1996) . An N-terminal leader peptide plays key roles in the sequential process, such as preventing intracellular activity of bacteriocin prepeptide or acting as a recognition signal either for modification or for the transport system (Chatterjee et al., 2005; Nes et al., 1996) .
In this respect, we initially focused our interest on the intracellular toxicity of LnqQ, as it is synthesized without an N-terminal leader peptide or intramolecular bridges (Fujita et al., 2007) . The in vitro synthesis of the LnqQ peptide showed a clear inhibition zone on the indicator lawn ( Fig. 2) , which indicated that LnqQ is translated in an active form. Consequently, the overexpression of LnqQ caused intracellular toxicity in L. lactis NZ9000, as it triggered growth suppression of the host cells (Fig. 3a) . In this experiment, we also performed the overexpression of the nukacin ISK-1 prepeptide (NukA), because nukacin ISK-1, a type AII lantibiotic, needs a modification enzyme (NukM) for its maturation (Nagao et al., 2005; Shioya et al., 2010) and thus, we assumed that no biological activity would result from NukA alone. This negative control reaction indicated that the overexpression of this small peptide (57 aa) does not trigger growth suppression of the host cells and thus highlighted the intracellular toxicity of LnqQ peptide. Previous work revealed that LnqQ damages cell membranes, even in the absence of specific receptors (Yoneyama et al., 2009a, b) . This may explain the intracellular toxicity of this peptide, even though the mechanism of how it acts intracellularly remains to be elucidated. As well as induced expression, constitutive expression of lnqQ also caused growth suppression of the host cells. In comparison with the control strain, L. lactis NZ9000 (pMGlnqQ) underwent a prolonged lag phase that was followed by a certain level of growth recovery (Fig. 5b) . It is noteworthy that the inoculation of the recovered cells into fresh culture medium also reproduced the same prolongation, following the recovery of host cell growth (data now shown). Meanwhile, the in vivo expression of lnqQ in L. lactis NZ9000 also revealed that LnqQ would not be secreted by a general secretory pathway of the host strain, indicating the presence of a dedicated transporter for LnqQ secretion.
The genetic similarity observed between lnqQ/lnqZ loci strongly suggested the involvement of ORF2q-7q (ORF2z-7z) in the production of these homologous bacteriocins. The ORF2q/2z, sharing similarities to putative transcriptional regulators, are potential regulators of LnqQ/Z production, The immunity levels of L. lactis NZ9000 recombinants against exogenous LnqQ were measured by using paper discs containing 10 ml twofold serially diluted LnqQ (10 mM). (b) The growth of each recombinant was monitored as described in the methods section. #, L. lactis NZ9000 pMG36c; g, L. lactis NZ9000 pMGlnqQ; h, L. lactis NZ9000 pLNQ. The data represent the mean value±SD of three independent experiments.
whereas ORF3q-7q (ORF3z-7z) are seemingly transcribed in the same operon and have functional roles in the secretion and/or the self-immunity of these bacteriocins. The latter hypothesis was confirmed by expression of orf3q-7q in a heterologous host L. lactis NZ9000. Constitutive expression of lnqQ and orf3q-7q in L. lactis NZ9000 (pLNQ) enabled the host cells to secrete LnqQ (Fig. 4) ; simultaneously, the expression of orf3q-7q rendered the host cells immune to LnqQ. This self-immunity is, in particular, facilitated by two means; firstly, secretion of LnqQ outside the cells, thus reducing the intracellular toxicity, and secondly, protection of the producer cells from extracellularly released LnqQ. The growth suppression caused by the expression of LnqQ alone (pMGlnqQ) was recovered by the additional expression of ORF3q-7q (Fig. 5b) ; furthermore, the recombinant cells exhibited enhanced immunity against exogenous LnqQ (Fig.  5a ). The differential immunity levels observed in L. lactis NZ9000 pLNQ and L. lactis NZ9000 pLNQDQ can be explained by the differential amount of LnqQ peptide existing on the culture plate. As L. lactis NZ9000 (pLNQ) both produced and secreted LnqQ, the cells were considered to be exposed to a higher concentration of LnqQ in the assay. Taken together, the orf3q-7q (orf3z-7z) are apparently involved in the biosynthesis of LnqQ (LnqZ), thus, these orf genes are hereafter referred to as lnqB-F (lnzB-F), respectively.
In the case of LsbB, a leaderless bacteriocin produced by a lactococcal strain, an ABC-type multi-drug efflux pump, termed LmrB, has been reported to facilitate the secretion of and immunity to the bacteriocin (Gajic et al., 2003) . Remarkably, LmrB shares a high degree of similarities with EntQB and AurT that are dedicated transporters for enterocin Q and aureocin A70, respectively, even though there is no sequence similarity in the structures of LsbB, enterocin Q and aureocin A70 (Criado et al., 2006; Netz et al., 2001) . Although none of the ORFs at the lnqQ/lnqZ loci showed similarity to LmrB, EntQB or AurT, it is likely that LnqE and LnqF (LnzE and LnzF) compose an ABCtransporter that has some homology to the product of orf3 and abc2 at the BHT-B locus. Despite the similarities of the bacteriocin structure, lnqQ/lnqZ loci have no similarity to aureocin A53 or epidermicin NI01 gene loci. However, the fact that all those gene loci encode an ABC-type transporter proposes a potential common mechanism of leaderless bacteriocins, in which one dedicated ABC-transporter mediates the functions of secretion and self-immunity of cognate bacteriocin.
In many of the class II bacteriocins, a membrane-associated protein has been found encoded near a transporter gene. The function(s) of those accessory proteins has not yet been clarified but is considered as essential in maintaining the localization and/or the function of the transporter (Nes et al., 1996) . This may explain the roles of LnqBCD (LnzBCD), as well as other membrane proteins found at BHT-B, aureocin A53 and epidermicin NI01 loci, in the production of this type of leaderless bacteriocin, although this hypothesis remains to be elucidated.
The present study is, to the best of our knowledge, the first report describing intracellular toxicity of a leaderless bacteriocin by both in vitro and in vivo experiments. This study also provides a rare but highly conserved genetic organization that is required for bacteriocin secretion and self-immunity. In addition, ORF2q and ORF2z (hereafter named as LnqR and LnzR) are putative TetR family proteins that are rarely found in bacteriocin gene regulation. Further studies are now encouraged to clarify the individual function of LnqB-F (LnzB-F), as well as the activity of LnqR/LnzR in the production of LnqQ/LnqZ.
